Biondvax Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Biondvax Pharmaceuticals (SCNI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Biondvax Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biondvax Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Biondvax Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $79k | 24k | 3.35 |
2024-09-30 | $104 | 30 | 3.47 |
2024-06-30 | $583 | 211 | 2.77 |
Top funds holding Biondvax Pharmaceuticals
View all funds holding Biondvax Pharmaceuticals